U.S. markets closed

Oncolytics Biotech Inc. (ONC.TO)

Toronto - Toronto Real Time Price. Currency in CAD
1.3500-0.0500 (-3.57%)
At close: 03:59PM EST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.4000
Bid1.3300 x 0
Ask1.3600 x 0
Day's Range1.3300 - 1.4000
52 Week Range1.2000 - 4.4900
Avg. Volume71,991
Market Cap99.088M
Beta (5Y Monthly)1.48
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for ONC.TO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Simply Wall St.

      Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation

      Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

    • Insider Monkey

      Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2023 Earnings Call Transcript

      Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2023 Earnings Call Transcript November 3, 2023 Oncolytics Biotech Inc. misses on earnings expectations. Reported EPS is $-0.1 EPS, expectations were $-0.07. Operator: Good morning, and welcome to Oncolytics Biotech’s Third Quarter 2023 Conference Call. All participants are now in listen-only mode. There will be a question-and-answer session at the […]

    • InvestorPlace

      3 Under-$20 Stocks to Buy for Explosive Returns

      A handful of stocks to buy under $20 can offer investors explosive returns in uncertain market conditions. The article lists names that might not immediately grab headlines, but their strategic focus and innovative progressiveness qualify them as potential multi-baggers. These three stocks to buy under $20 share a common thread of innovation and strategic alignment, making them interesting options for investors seeking financial growth and a stake in forward-looking industries. InvestorPlace - S